Please login to the form below

Not currently logged in
Email:
Password:

deutetrabenazine

This page shows the latest deutetrabenazine news and features for those working in and with pharma, biotech and healthcare.

Teva will have to endure revenue 'trough' in 2019

Teva will have to endure revenue 'trough' in 2019

To reverse the trend, Teva needs new products such as migraine prevention therapy Ajovy (fremanezumab) and Austedo (deutetrabenazine) for tardive dyskinesia and chorea associated with Huntington’s disease to ramp up

Latest news

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics